Comprehensive study to examine the effects of omalizumab in patients with bronchial asthma
Phase 4
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000002389
- Lead Sponsor
- Kyoto University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with hypersensitiviry to omalizumab 2)Patients with obstructive lung diseases such as chronic bronchitis or COPD, or bronchiectasis 3)Pregnancy or lactation 4)Patients with non-atopic diseases associated with elevated serum total IgE levels 5)Patients who are considered inappropriate by physicians in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method